Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jaffe

Showing results (781-790 of 1,423) with videos related to

Pageof 143
Sort By:
Clinical Biochemistry|August 28, 2013
Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assaysGus Koerbin, Walter P Abhayaratna, Julia M Potter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 19, 2014
Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventionsAlessandro Lupi, Andrea Rognoni, Maurizio Lazzero, et al.
Plos One|December 18, 2020
Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United StatesSaraschandra Vallabhajosyula, Vinayak Kumar, Pranathi R Sundaragiri, et al.
Journal of the American College of Cardiology|October 8, 1997
Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversionJ J Allan, R D Feld, A A Russell, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAlessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
American Journal of Clinical Pathology|December 1, 1994
Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expressionM Kuchnio, E A Sausville, E S Jaffe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survivalM T Keddis, Z M El-Zoghby, M El Ters, et al.
JACC. Advances|March 21, 2026
Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial InfarctionJonathan D Knott, Laura De Michieli, Olatunde Ola, et al.
Clinical Nuclear Medicine|November 6, 2019
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative SyndromeJorge A Carrasquillo, Clara C Chen, Susan Price, et al.
Pageof 143

Showing results (781-790 of 1,423) with videos related to

Sort By:
Pageof 143
Clinical Biochemistry|August 28, 2013
Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assaysGus Koerbin, Walter P Abhayaratna, Julia M Potter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 19, 2014
Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventionsAlessandro Lupi, Andrea Rognoni, Maurizio Lazzero, et al.
Plos One|December 18, 2020
Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United StatesSaraschandra Vallabhajosyula, Vinayak Kumar, Pranathi R Sundaragiri, et al.
Journal of the American College of Cardiology|October 8, 1997
Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversionJ J Allan, R D Feld, A A Russell, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAlessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
American Journal of Clinical Pathology|December 1, 1994
Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expressionM Kuchnio, E A Sausville, E S Jaffe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survivalM T Keddis, Z M El-Zoghby, M El Ters, et al.
JACC. Advances|March 21, 2026
Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial InfarctionJonathan D Knott, Laura De Michieli, Olatunde Ola, et al.
Clinical Nuclear Medicine|November 6, 2019
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative SyndromeJorge A Carrasquillo, Clara C Chen, Susan Price, et al.
Pageof 143